Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China) [Coronary Interventions]
Conclusions—
There are notable differences between guideline recommendations and the clinical management of patients with NSTE-ACS in China. The reasons for very-high-risk NSTE-ACS patients not undergoing PCI, and the optimal timing of PCI, require further clarification.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT02306616.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Yang, Q., Wang, Y., Liu, J., Liu, J., Hao, Y., Smith, S. C., Huo, Y., Fonarow, G. C., Ma, C., Ge, J., Taubert, K. A., Morgan, L., Guo, Y., Wang, W., Zhou, Y., Zhao, D., on behalf of the CCC-ACS Investigators Tags: Quality and Outcomes Coronary Interventions Source Type: research
More News: Angiography | Angioplasty | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Study